These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5926613)

  • 1. Active bone marrow distribution in the adult.
    Russell WJ; Yoshinagah ; Antoku S; Mizuno M
    Br J Radiol; 1966 Oct; 39(466):735-9. PubMed ID: 5926613
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of an electronic particle counter for studying the cell populations of bone marrow following irradiation].
    Khao Iu; Barakina NF
    Radiobiologiia; 1970; 10(6):874-7. PubMed ID: 5497340
    [No Abstract]   [Full Text] [Related]  

  • 3. [EVALUATION OF BONE MARROW CELL DISTRIBUTION IN THE DETERMINATION OF BONE MARROW DOSES IN SERIAL ROENTGENOLOGIC EXAMINATIONS].
    FRANZEN J
    Dtsch Med Wochenschr; 1965 Jan; 90():171-7. PubMed ID: 14238762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Destruction of bone marrow as a quantitative criterion of radiation injury. 1. Selection of the time for plotting the dose-effect curve].
    Kabakov EN; Perestoronina NN; Gorbunova VG
    Radiobiologiia; 1966; 6(6):779-82. PubMed ID: 5995849
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution of a breast-directed I-131-radiolabeled monoclonal antibody in blood and bone marrow: implications for radiation immunotherapy.
    Johnson TK; Gonzalez R; Kasliwal RK; Lear JL; Feyerabend AJ; Dienhart DG; Ceriani RL; Bunn PA
    Radiology; 1992 Jan; 182(1):107-14. PubMed ID: 1727271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of the method of studying the indices of bone marrow cellularity and mitotic index in the evaluation of the reaction to radiation].
    Shurupova EN; Baranov AE; Shantyr' VI; Kolesnikova GS; Burshteĭn ShA
    Med Radiol (Mosk); 1977 Apr; 22(4):47-52. PubMed ID: 875655
    [No Abstract]   [Full Text] [Related]  

  • 7. Interim Report on the determination of dose to bone marrow from radiological procedures.
    SPIERS FW
    Br J Radiol; 1963 Apr; 36():238-40. PubMed ID: 13990120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histomorphologic examinations of bone marrow of patients with gynecologic malignoma before, during, and after radiotherapy (author's transl)].
    Szalay S; Radaszkiewicz T; Kucera H; Michalica W
    Wien Klin Wochenschr; 1980 Apr; 92(9):317-21. PubMed ID: 6930763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up on the long-term effects of therapeutic irradiation on bone marrow.
    Sykes MP; Chu F; Gee TS; McKenzie S
    Radiology; 1974 Oct; 113(1):179-80. PubMed ID: 4423278
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative cytological bone marrow assessment as a base for the evaluation of the regeneration course after therapeutic x-ray irradiation].
    Klare KH; Wölfling M; Kammerer R
    Radiobiol Radiother (Berl); 1972; 13(1):41-54. PubMed ID: 5035442
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone-marrow dose produced by radioactive isotopes.
    HOLODNY E; LECHTMAN H; LAUGHLIN JS
    Radiology; 1961 Jul; 77():1-11. PubMed ID: 13715506
    [No Abstract]   [Full Text] [Related]  

  • 12. [ESTIMATION OF BONE MARROW FROM RADIOGRAPHY OF X-RAY EXAMINATION].
    HASHIZUME T; KATO Y; MARUYAMA T; SHIRAGAI A; MARUYAMA S; TAKIZAWA M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 Dec; 24():1087-93. PubMed ID: 14280619
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinically useful marrow dosimetry for targeted radionuclide therapy.
    Shen S; Meredith RF
    Cancer Biother Radiopharm; 2005 Apr; 20(2):119-22. PubMed ID: 15869444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy].
    Marcolongo R; Di Paolo N; Bianco G; Bravi A
    Haematologica; 1969; 54(9):603-26. PubMed ID: 4994340
    [No Abstract]   [Full Text] [Related]  

  • 15. Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry.
    Siegel JA
    Cancer Biother Radiopharm; 2005 Apr; 20(2):126-40. PubMed ID: 15869446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Means of reducing somatic radiation hazards].
    Franzen J
    Fortschr Geb Rontgenstr Nuklearmed; 1966 Dec; 105(6):893-9. PubMed ID: 6011971
    [No Abstract]   [Full Text] [Related]  

  • 17. [A method for estimation of active bone marrow dose from x-ray radiography (author's transl)].
    Takaku Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1975 Aug; 35(8):685-91. PubMed ID: 1061944
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the blood elements, serum proteins as well as sternal bone marrow during and after x-irradiation of he thoracic wall in breast carcinoma].
    Spoljar M; Zunter F; Kubovic M; Premuzic B; Konstantinovic M
    Strahlentherapie; 1967 Jun; 133(2):238-44. PubMed ID: 5589955
    [No Abstract]   [Full Text] [Related]  

  • 19. Calculation of the radiation dose at a bone-to-marrow interface.
    van Dieren EB; Plaizier MA; Roos JC; Teule GJ; van Lingen A
    J Nucl Med; 1992 Oct; 33(10):1915-6. PubMed ID: 1403167
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosage measurements in bone marrow of infants in therapeutic and diagnostic x-ray exposures].
    PAPAGNI L; ROSEO B
    Fortschr Geb Rontgenstr Nuklearmed; 1960 Sep; 93():281-6. PubMed ID: 13732610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.